Delirium
Market Industry Research Report: By Type (Hyperactive, Hypoactive, Mixed),
Treatment (Antipsychotics, Supportive Care), Diagnosis (Laboratory Tests,
Imaging Tests, Physical Examination), End-User (Hospitals, Specialty Centers) –
Global Forecast Till 2023
Market Highlights
The Global Delirium Market Industry
is expected to grow at a CAGR of 6% during the forecast period. Delirium is a
neurological (nervous system) condition and is a serious disturbance in mental
abilities that causes mental confusion and emotional disruption. Delirium can
be caused due to various factors such as older age, exposure to certain
medications, alcohol abuse, surgery or other medical procedures, factors such
as exposure to toxic or infectious agents, physical trauma, diet, and
behavioral and occupational factors.
Key Players
Some of the key players in the Delirium
Market Industryare Dr. Franz Kohler Chemie GmbH, Fraser Health, Gaia BioPharma
Ltd., Novartis AG, Pfizer, Inc., Regenstrief Institute, Inc., and Air Liquide
Sante International, among others.
Regional Analysis
The Americas dominates the global Delirium
Market Industryowing to the increasing aging population and increasing rate of
neurological conditions. Additionally, the increasing government initiatives
and awareness programs are likely to enhance the growth of delirium in the
North American region. Similarly, increasing government healthcare costs, along
with the increasing awareness among population regarding mental health is
expected to drive the growth of the Delirium Market Industryin North America.
For instance, iDelirium, a federation of 3 delirium societies (American
Delirium Society, European Delirium Society, and Australasian Delirium
Association) has launched various awareness programs across the country to
spread awareness regarding delirium and its effects.
Europe accounts for the second
largest market due to increasing aging mass and increasing neurological
disorders. Additionally, the improving government funding and increasing
healthcare infrastructure along with the increasing demand for technologically
advanced treatment are driving the growth of Delirium Market Industryin Europe.
For instance, Eurostat estimated that over 19.2% of the population in Europe
was aged 65 and above. This rising older population is likely to drive the
growth of the delirium market.
Asia Pacific is the fastest growing
market for delirium whose growth is attributed to the increasing population
which in turn increases the overall patient population and rising population
affected by post-surgical disorders. India and China are the primary
contributors to the market growth due to the rising demand for advanced and
newer treatments and rising development of healthcare infrastructure in these
regions.
On the other hand, the Middle East
and Africa is expected to witness a restricted growth due to limited access and
affordability of the healthcare system and lack of awareness among individuals.
In the Middle East, the growth of the market is driven by the growing awareness
regarding neurological disorders and expanding healthcare scenario.
Segmentation
The global Delirium Market Industry is
segmented on the basis of type, treatment, diagnosis, and end-user.
On the basis of type, the market is
segmented into hyperactive, hypoactive, and mixed.
On the basis of diagnosis, the
market is segmented into laboratory tests, imaging tests, and physical
examination. On the basis of laboratory tests, it is further sub-segmented into
blood tests and urine tests. On the basis of imaging tests, it is further
sub-segmented into brain-imaging tests.
On the basis of treatment, the
market is segmented into antipsychotics and supportive care. On the basis of
treatment, antipsychotics is further sub-segmented into risperidone,
olanzapine, and quetiapine.
On the basis of end-user, the market
is segmented into specialty centers, hospitals, and research centers.
No comments:
Post a Comment